Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Renal Cell × tazemetostat × 30 days × Clear all

Sponsor

Conditions

Lymphoma, Follicular 2 Urinary Bladder Neoplasms 1 Tertiary Lymphoid Structures 1 Solid Tumor 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Melanoma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, T-Cell 1 Lymphoma, Non-Hodgkin 1 Lymphoma, B-Cell 1 Leukemia, Myeloid, Acute 1 Colorectal Neoplasms 1 Carcinoma, Transitional Cell 1

Interventions

Nivolumab 18 cabozantinib 14 Magnetic Resonance Spectroscopy 14 Specimen Handling 12 Ipilimumab 12 pembrolizumab 11 lenvatinib 5 Biopsy 5 atezolizumab 4 Immunoglobulin G 4 Everolimus 4 CTLA-4 Antigen 4 Axitinib 4 pazopanib 3 cemiplimab 3 Disulfides 3 Bevacizumab 3 zimberelimab 2 toripalimab 2 tivozanib 2 spartalizumab 2 belzutifan 2 aflibercept 2 Watchful Waiting 2 Pluvicto 2 Nephrectomy 2 trastuzumab deruxtecan 1 temsirolimus 1 sitravatinib 1 sargramostim 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡